Home
Conditions
Neoplasms, Squamous Cell

Clinical trial condition

Neoplasms, Squamous Cell

Explore clinical trials studying Neoplasms, Squamous Cell. Study availability and eligibility vary by location and protocol.

815 public trials 209 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Squamous Cell trial results

Recruiting

Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC

NCT05507411

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU) Hanzhou, Zhejiang, China

Zhejiang Cancer Hospital Hanzhou, Zhejiang, China

Ningbo Medical Center Lihuili Hospital Ningbo, Zhejiang, China

View Trial Details

Recruiting

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

NCT04138212

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody

NCT05392413

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Nanfang Hospital Guangzhou, China

View Trial Details

Recruiting

Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC

NCT04973306

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations: Shanghai Zhongshan Hospital Shanghai, China

View Trial Details

Recruiting

Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)

NCT04807673

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma

NCT04009265

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Recruiting

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

NCT04018872

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +17 more
Locations: Dallas VA Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

NCT04519905

Conditions: Carcinoma, Carcinoma, Squamous Cell, Chemoradiotherapy, +14 more
Locations: Jiangsu Cancer Hospital Nanjing, Jiangsu, China

Huadong Hospital Shanghai, Shanghai Municipality, China

Fudan Universtiy Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer

NCT04522687

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by Invitation

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

NCT07218003

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
Locations: UCSF Medical Center San Francisco, California, United States

Yale Cancer Center New Haven, Connecticut, United States

START Midwest Grand Rapids, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Neoplasms, Squamous Cell

Neoplasms, Squamous Cell trial results

Related conditions